Compile Data Set for Download or QSAR
Report error Found 340 Enz. Inhib. hit(s) with all data for entry = 9425
TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465458(US10793568, Compound I-110)
Affinity DataEC50:  0.100nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465567(US10793568, Compound I-217)
Affinity DataEC50:  0.126nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465447(US10793568, Compound I-101)
Affinity DataEC50:  0.158nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465515(US10793568, Compound I-164)
Affinity DataEC50:  0.200nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465399(US10793568, Compound I-18)
Affinity DataEC50:  0.200nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465473(US10793568, Compound I-124)
Affinity DataEC50:  0.200nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465464(US10793568, Compound I-115)
Affinity DataEC50:  0.251nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465576(US10793568, Compound I-226)
Affinity DataEC50:  0.251nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465471(US10793568, Compound I-122)
Affinity DataEC50:  0.251nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465575(US10793568, Compound I-225)
Affinity DataEC50:  0.316nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465460(US10793568, Compound I-112)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465457(US10793568, Compound I-109)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465453(US10793568, Compound I-105)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465521(US10793568, Compound I-170)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465487(US10793568, Compound I-135)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465452(US10793568, Compound I-104)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465566(US10793568, Compound I-216)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465563(US10793568, Compound I-213)
Affinity DataEC50:  0.398nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465459(US10793568, Compound I-111)
Affinity DataEC50:  0.501nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465477(US10793568, Compound I-127)
Affinity DataEC50:  0.501nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465562(US10793568, Compound I-212)
Affinity DataEC50:  0.631nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465636(US10793568, Compound I-287)
Affinity DataEC50:  0.631nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465524(US10793568, Compound I-173)
Affinity DataEC50:  0.631nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465538(US10793568, Compound I-187)
Affinity DataEC50:  0.631nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465504(US10793568, Compound I-153)
Affinity DataEC50:  0.631nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465601(US10793568, Compound I-251)
Affinity DataEC50:  0.794nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465456(US10793568, Compound I-108)
Affinity DataEC50:  0.794nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465491(US10793568, Compound I-140)
Affinity DataEC50:  0.794nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465544(US10793568, Compound I-194)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465683(US10793568, Compound I-334)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465393(US10793568, Compound I-12)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465604(US10793568, Compound I-254)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465553(US10793568, Compound I-203)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465633(US10793568, Compound I-284)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465646(US10793568, Compound I-297)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465678(US10793568, Compound I-329)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465692(US10793568, Compound I-343)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465488(US10793568, Compound I-136)
Affinity DataEC50:  1nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465687(US10793568, Compound I-338)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465634(US10793568, Compound I-285)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465409(US10793568, Compound I-28)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465536(US10793568, Compound I-185)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465537(US10793568, Compound I-186)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465501(US10793568, Compound I-150)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465533(US10793568, Compound I-182)
Affinity DataEC50:  1.26nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465545(US10793568, Compound I-195)
Affinity DataEC50:  1.58nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465609(US10793568, Compound I-260)
Affinity DataEC50:  1.58nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465571(US10793568, Compound I-221)
Affinity DataEC50:  1.58nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465724(US10793568, Compound I-54)
Affinity DataEC50:  1.58nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargetBile acid receptor(Human)
Ardelyx

US Patent
LigandPNGBDBM465532(US10793568, Compound I-181)
Affinity DataEC50:  1.58nMAssay Description:The affinity of FXR ligands for the ligand binding domain of FXR was determined using a commercially available human FXR ligand binding assay (Lantha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 340 total ) | Next | Last >>
Jump to: